![Takashi Masai](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Takashi Masai
Keine laufenden Positionen mehr
Karriereverlauf von Takashi Masai
Ehemalige bekannte Positionen von Takashi Masai
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Marunouchi Capital Co., Ltd.
![]() Marunouchi Capital Co., Ltd. Investment ManagersFinance Marunouchi Capital Co., Ltd. (Marunouchi Capital) is a private equity firm headquartered in Tokyo, Japan. The firm was founded in 2008 by Mitsubishi Corp. and Mitsubishi UFJ Securities Co., Ltd. | Private Equity Investor | 10.08.2010 | 01.03.2011 |
ReproCELL USA, Inc.
![]() ReproCELL USA, Inc. Medical/Nursing ServicesHealth Services ReproCELL USA, Inc. is based in Beltsville, MD. Part of ReproCELL, Inc., ReproCELL USA, Inc. is a company that engages in iPS cell research business. | Direktor/Vorstandsmitglied | 01.12.2012 | - |
REPROCELL INCORPORATED | Direktor/Vorstandsmitglied | 01.02.2013 | - |
Vertrieb & Marketing | 01.02.2013 | - |
Ausbildung von Takashi Masai
Tohoku University | Graduate Degree |
Statistik
International
Japan | 4 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 2 |
Private Equity Investor | 1 |
Sales & Marketing | 1 |
Sektoral
Finance | 2 |
Health Technology | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
REPROCELL INCORPORATED | Health Technology |
Private Unternehmen | 2 |
---|---|
Marunouchi Capital Co., Ltd.
![]() Marunouchi Capital Co., Ltd. Investment ManagersFinance Marunouchi Capital Co., Ltd. (Marunouchi Capital) is a private equity firm headquartered in Tokyo, Japan. The firm was founded in 2008 by Mitsubishi Corp. and Mitsubishi UFJ Securities Co., Ltd. | Finance |
ReproCELL USA, Inc.
![]() ReproCELL USA, Inc. Medical/Nursing ServicesHealth Services ReproCELL USA, Inc. is based in Beltsville, MD. Part of ReproCELL, Inc., ReproCELL USA, Inc. is a company that engages in iPS cell research business. | Health Services |
- Börse
- Insiders
- Takashi Masai
- Erfahrung